{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T18:29:49Z","timestamp":1784917789661,"version":"3.55.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007706","name":"Ministero dello Sviluppo Economico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007706","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005924","name":"International Association for the Study of Pain","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004462","name":"National Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004462","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicon"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.toxicon.2025.108250","type":"journal-article","created":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T08:25:54Z","timestamp":1737620754000},"page":"108250","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["BoNT\/Action beyond neurons"],"prefix":"10.1016","volume":"255","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5393-4796","authenticated-orcid":false,"given":"Sara","family":"Marinelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.toxicon.2025.108250_bib1","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.tcb.2011.06.004","article-title":"Central nervous system myelin: structure, synthesis and assembly","volume":"21","author":"Aggarwal","year":"2011","journal-title":"Trends Cell Biol."},{"issue":"9","key":"10.1016\/j.toxicon.2025.108250_bib2","doi-asserted-by":"crossref","first-page":"550","DOI":"10.3390\/toxins15090550","article-title":"Action of botulinum neurotoxin E type in experimental epilepsies","volume":"15","author":"Antonucci","year":"2023","journal-title":"Toxins"},{"issue":"14","key":"10.1016\/j.toxicon.2025.108250_bib3","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1523\/JNEUROSCI.0375-08.2008","article-title":"Long-distance retrograde effects of botulinum neurotoxin A","volume":"28","author":"Antonucci","year":"2008","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.toxicon.2025.108250_bib4","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1111\/j.1528-1167.2008.01983.x","article-title":"Intrahippocampal infusion of botulinum neurotoxin E (BoNT\/E) reduces spontaneous recurrent seizures in a mouse model of mesial temporal lobe epilepsy","volume":"50","author":"Antonucci","year":"2009","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.toxicon.2025.108250_bib5","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.pbb.2009.08.012","article-title":"Central origin of the antinociceptive action of botulinum toxin type A","volume":"94","author":"Bach-Rojecky","year":"2009","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.toxicon.2025.108250_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105952","article-title":"Schwann cell functions in peripheral nerve development and repair","volume":"176","author":"Bosch-Queralt","year":"2023","journal-title":"Neurobiol. Dis."},{"issue":"5","key":"10.1016\/j.toxicon.2025.108250_bib7","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.toxicon.2008.12.026","article-title":"Central effects of tetanus and botulinum neurotoxins","volume":"54","author":"Caleo","year":"2009","journal-title":"Toxicon"},{"issue":"7","key":"10.1016\/j.toxicon.2025.108250_bib8","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/j.1526-4637.2011.01135.x","article-title":"Human response to unintended intrathecal injection of botulinum toxin","volume":"12","author":"Carroll","year":"2011","journal-title":"Pain Med."},{"issue":"9","key":"10.1016\/j.toxicon.2025.108250_bib9","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1002\/jnr.24856","article-title":"The synaptic blocker botulinum toxin A decreases the density and complexity of oligodendrocyte precursor cells in the adult mouse hippocampus","volume":"99","author":"Chacon-De-La-Rocha","year":"2021","journal-title":"J. Neurosci. Res."},{"issue":"3","key":"10.1016\/j.toxicon.2025.108250_bib10","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.neuron.2017.06.029","article-title":"Neural circuit-specialized astrocytes: transcriptomic, proteomic, morphological, and functional evidence","volume":"95","author":"Chai","year":"2017","journal-title":"Neuron"},{"issue":"10","key":"10.1016\/j.toxicon.2025.108250_bib11","doi-asserted-by":"crossref","first-page":"913","DOI":"10.3390\/toxins4100913","article-title":"Clinical uses of botulinum neurotoxins: current indications, limitations and future developments","volume":"4","author":"Chen","year":"2012","journal-title":"Toxins"},{"issue":"1","key":"10.1016\/j.toxicon.2025.108250_bib12","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s10194-021-01254-2","article-title":"Unilateral facial injection of Botulinum neurotoxin A attenuates bilateral trigeminal neuropathic pain and anxiety-like behaviors through inhibition of TLR2-mediated neuroinflammation in mice","volume":"22","author":"Chen","year":"2021","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.toxicon.2025.108250_bib13","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.neuroscience.2017.07.011","article-title":"Botulinum neurotoxin A promotes functional recovery after peripheral nerve injury by increasing regeneration of myelinated fibers","volume":"359","author":"Cobianchi","year":"2017","journal-title":"Neuroscience"},{"issue":"12","key":"10.1016\/j.toxicon.2025.108250_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0208596","article-title":"Effects of caloric restriction on neuropathic pain, peripheral nerve degeneration and inflammation in normometabolic and autophagy defective prediabetic Ambra1 mice","volume":"13","author":"Coccurello","year":"2018","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.toxicon.2025.108250_bib15","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1002\/ejp.513","article-title":"Intrathecal administration of botulinum toxin type A improves urinary bladder function and reduces pain in rats with cystitis","volume":"18","author":"Coelho","year":"2014","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.toxicon.2025.108250_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2022.114069","article-title":"New insights into peripheral nerve regeneration: the role of secretomes","volume":"354","author":"Contreras","year":"2022","journal-title":"Exp. Neurol."},{"issue":"5","key":"10.1016\/j.toxicon.2025.108250_bib17","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3390\/toxins15050332","article-title":"Safety of onabotulinumtoxin A in chronic migraine: a systematic review and meta-analysis of randomized clinical trials","volume":"15","author":"Corasaniti","year":"2023","journal-title":"Toxins"},{"issue":"8","key":"10.1016\/j.toxicon.2025.108250_bib18","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1111\/jcmm.12562","article-title":"Botulinum neurotoxin type A modulates vesicular release of glutamate from satellite glial cells","volume":"19","author":"da Silva","year":"2015","journal-title":"J. Cell Mol. Med."},{"issue":"23","key":"10.1016\/j.toxicon.2025.108250_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232314503","article-title":"Sex differences in neuropathy: the paradigmatic case of metformin","volume":"23","author":"De Angelis","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"7981","key":"10.1016\/j.toxicon.2025.108250_bib20","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41586-023-06502-w","article-title":"Specialized astrocytes mediate glutamatergic gliotransmission in the CNS","volume":"622","author":"de","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.toxicon.2025.108250_bib21","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.pneurobio.2016.03.009","article-title":"Targeting astrocytes in CNS injury and disease: a translational research approach","volume":"144","author":"Filous","year":"2016","journal-title":"Prog. Neurobiol."},{"issue":"3","key":"10.1016\/j.toxicon.2025.108250_bib22","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3390\/toxins10030128","article-title":"Botulinum toxin B affects neuropathic pain but not functional recovery after peripheral nerve injury in a mouse model","volume":"10","author":"Finocchiaro","year":"2018","journal-title":"Toxins"},{"issue":"1","key":"10.1016\/j.toxicon.2025.108250_bib23","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41392-023-01588-0","article-title":"Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets","volume":"8","author":"Gao","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"1","key":"10.1016\/j.toxicon.2025.108250_bib24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00401-009-0622-0","article-title":"Microglia: biology and pathology","volume":"119","author":"Graeber","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.toxicon.2025.108250_bib25","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13578-020-00405-3","article-title":"Botulinum toxin type A promotes microglial M2 polarization and suppresses chronic constriction injury-induced neuropathic pain through the P2X7 receptor","volume":"10","author":"Gui","year":"2020","journal-title":"Cell Biosci."},{"issue":"9","key":"10.1016\/j.toxicon.2025.108250_bib26","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41583-020-0333-z","article-title":"Emerging importance of satellite glia in nervous system function and dysfunction","volume":"21","author":"Hanani","year":"2020","journal-title":"Nat. Rev. Neurosci."},{"issue":"13","key":"10.1016\/j.toxicon.2025.108250_bib27","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2022112095","article-title":"Presynaptic targeting of botulinum neurotoxin type A requires a tripartite PSG-Syt1-SV2 plasma membrane nanocluster for synaptic vesicle entry","volume":"42","author":"Joensuu","year":"2023","journal-title":"EMBO J."},{"issue":"31","key":"10.1016\/j.toxicon.2025.108250_bib28","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abh2169","article-title":"A single-cell type transcriptomics map of human tissues","volume":"7","author":"Karlsson","year":"2021","journal-title":"Sci. Adv."},{"issue":"2","key":"10.1016\/j.toxicon.2025.108250_bib29","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1152\/physrev.00011.2010","article-title":"Physiology of microglia","volume":"91","author":"Kettenmann","year":"2011","journal-title":"Physiol. Rev."},{"issue":"7","key":"10.1016\/j.toxicon.2025.108250_bib30","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nn.4043","article-title":"Diversity of astrocyte functions and phenotypes in neural circuits","volume":"18","author":"Khakh","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.toxicon.2025.108250_bib31","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3389\/fneur.2014.00098","article-title":"Spinal central effects of peripherally applied botulinum neurotoxin A in comparison between its subtypes A1 and A2","volume":"5","author":"Koizumi","year":"2014","journal-title":"Front. Neurol."},{"issue":"4","key":"10.1016\/j.toxicon.2025.108250_bib32","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1017\/S1740925X08000045","article-title":"Acetylcholine inhibits cell cycle progression in rat Schwann cells by activation of the M2 receptor subtype","volume":"3","author":"Loreti","year":"2007","journal-title":"Neuron Glia Biol."},{"issue":"3","key":"10.1016\/j.toxicon.2025.108250_bib33","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/01.fbp.0000129746.14753.1e","article-title":"Central injection of botulinum neurotoxins: behavioural effects in mice","volume":"15","author":"Luvisetto","year":"2004","journal-title":"Behav. Pharmacol."},{"issue":"1","key":"10.1016\/j.toxicon.2025.108250_bib34","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.brainres.2006.01.117","article-title":"Botulinum neurotoxins and formalin-induced pain: central vs. peripheral effects in mice","volume":"1082","author":"Luvisetto","year":"2006","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.toxicon.2025.108250_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroscience.2006.12.004","article-title":"Anti-allodynic efficacy of botulinum neurotoxin A in a model of neuropathic pain","volume":"145","author":"Luvisetto","year":"2007","journal-title":"Neuroscience"},{"issue":"450","key":"10.1016\/j.toxicon.2025.108250_bib36","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aar7384","article-title":"Selective neuronal silencing using synthetic botulinum molecules alleviates chronic pain in mice","volume":"10","author":"Maiar\u00f9","year":"2018","journal-title":"Sci. Transl. Med."},{"issue":"6","key":"10.1016\/j.toxicon.2025.108250_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpain.2024.01.331","article-title":"Substance P-botulinum mediates long-term silencing of pain pathways that can be Re-instated with a second injection of the construct in mice","volume":"25","author":"Maiar\u00f9","year":"2024","journal-title":"J. Pain"},{"issue":"11","key":"10.1016\/j.toxicon.2025.108250_bib38","doi-asserted-by":"crossref","first-page":"9772","DOI":"10.3390\/ijms24119772","article-title":"Role of SNAREs and rabs in myelin regulation","volume":"24","author":"Margiotta","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.toxicon.2025.108250_bib39","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.neuroscience.2010.08.067","article-title":"Botulinum neurotoxin type A counteracts neuropathic pain and facilitates functional recovery after peripheral nerve injury in animal models","volume":"171","author":"Marinelli","year":"2010","journal-title":"Neuroscience"},{"issue":"10","key":"10.1016\/j.toxicon.2025.108250_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047977","article-title":"The analgesic effect on neuropathic pain of retrogradely transported botulinum neurotoxin A involves Schwann cells and astrocytes","volume":"7","author":"Marinelli","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.toxicon.2025.108250_bib41","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.pain.2013.09.013","article-title":"Schwann cell autophagy counteracts the onset and chronification of neuropathic pain","volume":"155","author":"Marinelli","year":"2014","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.toxicon.2025.108250_bib42","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/glia.24281","article-title":"Endocannabinoid signaling in microglia","volume":"71","author":"Marinelli","year":"2023","journal-title":"Glia"},{"key":"10.1016\/j.toxicon.2025.108250_bib43","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ejogrb.2023.04.019","article-title":"Uterine botulinum toxin injections in severe dysmenorrhea, dyspareunia and chronic pelvic pain: results on quality of life, pain level and medical consumption","volume":"285","author":"Martial Kouame","year":"2023","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"8","key":"10.1016\/j.toxicon.2025.108250_bib44","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.tins.2006.06.008","article-title":"D-serine signalling in the brain: friend and foe","volume":"29","author":"Martineau","year":"2006","journal-title":"Trends Neurosci."},{"issue":"8","key":"10.1016\/j.toxicon.2025.108250_bib45","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2340\/16501977-2257","article-title":"Centrally mediated late motor recovery after botulinum toxin injection: case reports and a review of current evidence","volume":"49","author":"Mas","year":"2017","journal-title":"J. Rehabil. Med."},{"issue":"4","key":"10.1016\/j.toxicon.2025.108250_bib46","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3390\/toxins15040248","article-title":"Xeomin\u00ae, a commercial formulation of botulinum neurotoxin type A, promotes regeneration in a preclinical model of spinal cord injury","volume":"15","author":"Mastrorilli","year":"2023","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2025.108250_bib47","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.neuroscience.2010.11.040","article-title":"The effect of botulinum neurotoxin A on sciatic nerve injury-induced neuroimmunological changes in rat dorsal root ganglia and spinal cord","volume":"175","author":"Mika","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.toxicon.2025.108250_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.742065","article-title":"Microglia in neuroinflammation and neurodegeneration: from understanding to therapy","volume":"15","author":"Muzio","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.toxicon.2025.108250_bib51","unstructured":"National Hospital For Neurology And Neurosurgery; Europainclinics Z.\u00da; Botox vs Spinal Cord Stimulation in the Treatment of Refractory Migraine Clinical Trial, 2022-08-02 Clinical Trial Europainclincs."},{"key":"10.1016\/j.toxicon.2025.108250_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111462","article-title":"Brivaracetam prevents astroglial l-glutamate release associated with hemichannel through modulation of synaptic vesicle protein","volume":"138","author":"Okada","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"7","key":"10.1016\/j.toxicon.2025.108250_bib53","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3390\/toxins16070309","article-title":"Clinical conditions targeted by OnabotulinumtoxinA in different ways in medicine","volume":"16","author":"Onan","year":"2024","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2025.108250_bib54","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3389\/fcimb.2017.00141","article-title":"Comparison of the expression changes after botulinum toxin type A and minocycline administration in lipopolysaccharide-stimulated rat microglial and astroglial cultures","volume":"7","author":"Piotrowska","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"2","key":"10.1016\/j.toxicon.2025.108250_bib55","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1124\/pr.116.012658","article-title":"Botulinum neurotoxins: biology, pharmacology, and toxicology","volume":"69","author":"Pirazzini","year":"2017","journal-title":"Pharmacol. Rev."},{"issue":"6","key":"10.1016\/j.toxicon.2025.108250_bib56","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3390\/toxins16060261","article-title":"Embracing the versatility of botulinum neurotoxins in conventional and new therapeutic applications","volume":"16","author":"Rasetti-Escargueil","year":"2024","journal-title":"Toxins"},{"issue":"44","key":"10.1016\/j.toxicon.2025.108250_bib57","doi-asserted-by":"crossref","first-page":"15650","DOI":"10.1523\/JNEUROSCI.2618-11.2011","article-title":"Evidence for anterograde transport and transcytosis of botulinum neurotoxin A (BoNT\/A)","volume":"31","author":"Restani","year":"2011","journal-title":"J. Neurosci."},{"issue":"12","key":"10.1016\/j.toxicon.2025.108250_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003087","article-title":"Botulinum neurotoxins A and E undergo retrograde axonal transport in primary motor neurons","volume":"8","author":"Restani","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.toxicon.2025.108250_bib59","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3390\/toxins10040145","article-title":"Botulinum toxin type A\u2014a modulator of spinal neuron\u2013glia interactions under neuropathic pain conditions","volume":"10","author":"Rojewska","year":"2018","journal-title":"Toxins"},{"issue":"9","key":"10.1016\/j.toxicon.2025.108250_bib60","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.tins.2023.06.001","article-title":"Three players in the 'toxic affair' between botulinum neurotoxin type A and neurons","volume":"46","author":"Rossetto","year":"2023","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.toxicon.2025.108250_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.176242","article-title":"Beyond neuromuscular activity: botulinum toxin type A exerts direct central action on spinal control of movement","volume":"962","author":"\u0160o\u0161tari\u0107","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.toxicon.2025.108250_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxicon.2023.107208","article-title":"Botulinum toxin A and neuropathic pain: an update","volume":"232","author":"Spagna","year":"2023","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2025.108250_bib63","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.toxicon.2012.11.011","article-title":"Botulinum neurotoxins: mechanism of action","volume":"67","author":"Tighe","year":"2013","journal-title":"Toxicon"},{"issue":"3","key":"10.1016\/j.toxicon.2025.108250_bib64","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/jdb4030028","article-title":"Hedgehog: a key signaling in the development of the oligodendrocyte lineage","volume":"4","author":"Traiffort","year":"2016","journal-title":"J. Dev. Biol."},{"issue":"6220","key":"10.1016\/j.toxicon.2025.108250_bib65","doi-asserted-by":"crossref","DOI":"10.1126\/science.1260419","article-title":"Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.toxicon.2025.108250_bib66","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3390\/toxins12080491","article-title":"Revealing the therapeutic potential of Botulinum Neurotoxin Type A in counteracting paralysis and neuropathic pain in spinally injured mice","volume":"12","author":"Vacca","year":"2020","journal-title":"Toxins"},{"issue":"1","key":"10.1016\/j.toxicon.2025.108250_bib67","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1046\/j.1471-4159.1999.0720327.x","article-title":"Proteolysis of SNAP-25 isoforms by botulinum neurotoxin types A, C, and E: domains and amino acid residues controlling the formation of enzyme-substrate complexes and cleavage","volume":"72","author":"Vaidyanathan","year":"1999","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.toxicon.2025.108250_bib68","doi-asserted-by":"crossref","first-page":"239","DOI":"10.15252\/embj.201592705","article-title":"Astrocytes as secretory cells of the central nervous system: idiosyncrasies of vesicular secretion","volume":"35","author":"Verkhratsky","year":"2016","journal-title":"EMBO J."},{"key":"10.1016\/j.toxicon.2025.108250_bib69","doi-asserted-by":"crossref","unstructured":"Wang J, et al. SNAP-25-mediated astrocyte activation in CCI models. Neuroscience, 423, 86-97. doi: 10.1016\/j.neuroscience.2019.09.011.","DOI":"10.1016\/j.neuroscience.2019.10.007"},{"issue":"1","key":"10.1016\/j.toxicon.2025.108250_bib70","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s13578-020-00501-4","article-title":"Botulinum toxin type A alleviates neuropathic pain and suppresses inflammatory cytokines release from microglia by targeting TLR2\/MyD88 and SNAP23","volume":"10","author":"Wang","year":"2020","journal-title":"Cell Biosci."},{"issue":"1","key":"10.1016\/j.toxicon.2025.108250_bib71","doi-asserted-by":"crossref","first-page":"36","DOI":"10.5213\/inj.2244220.110","article-title":"The comparative effectiveness of botulinum toxin-A injection therapy versus augmentation uretero-enterocystoplasty for the treatment of lower urinary tract dysfunction","volume":"27","author":"Wang","year":"2023","journal-title":"Int. Neurourol. J."},{"issue":"7","key":"10.1016\/j.toxicon.2025.108250_bib72","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/j.1526-4637.2011.01164.x","article-title":"Spinal toxins can have persistent adverse effects","volume":"12","author":"Yaksh","year":"2011","journal-title":"Pain Med."},{"issue":"1","key":"10.1016\/j.toxicon.2025.108250_bib73","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1038\/s41467-024-47322-4","article-title":"Structural basis for antiepileptic drugs and botulinum neurotoxin recognition of SV2A","volume":"15","author":"Yamagata","year":"2024","journal-title":"Nat. Commun."},{"issue":"18","key":"10.1016\/j.toxicon.2025.108250_bib74","doi-asserted-by":"crossref","first-page":"6391","DOI":"10.1523\/JNEUROSCI.6221-11.2012","article-title":"Genomic analysis of reactive astrogliosis","volume":"32","author":"Zamanian","year":"2012","journal-title":"J. Neurosci."},{"issue":"10","key":"10.1016\/j.toxicon.2025.108250_bib75","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1007\/s11064-023-03969-x","article-title":"Intrathecal injection of botulinum toxin type A has an analgesic effect in male rats CCI model by inhibiting the activation of spinal P2X4R","volume":"48","author":"Zhou","year":"2023","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.toxicon.2025.108250_bib76","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ejphar.2016.09.019","article-title":"Participation of pro- and anti-nociceptive interleukins in botulinum toxin A-induced analgesia in a rat model of neuropathic pain","volume":"791","author":"Zychowska","year":"2016","journal-title":"Eur. J. Pharmacol."}],"container-title":["Toxicon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010125000248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010125000248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T10:48:15Z","timestamp":1740394095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041010125000248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":74,"alternative-id":["S0041010125000248"],"URL":"https:\/\/doi.org\/10.1016\/j.toxicon.2025.108250","relation":{},"ISSN":["0041-0101"],"issn-type":[{"value":"0041-0101","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BoNT\/Action beyond neurons","name":"articletitle","label":"Article Title"},{"value":"Toxicon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxicon.2025.108250","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108250"}}